Modern Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Modern Wealth Management's BIIB Position: Q2 2026 in Review
Modern Wealth Management increased its Biogen (BIIB) stake by 6.3% in Q2 2026, buying an estimated $18.4K and bringing the position to 1,625 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #820.
Modern Wealth Management first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Modern Wealth Management held 1,625 shares of Biogen worth $351K as of Q2 2026.
- Modern Wealth Management bought 96 Biogen shares in Q2 2026, an estimated $18.4K.
- Biogen made up ﹤0.01% of Modern Wealth Management's portfolio in Q2 2026, its #820 holding.
- Modern Wealth Management first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.